Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: phase II study.
about
Bone and brain metastasis in lung cancer: recent advances in therapeutic strategiesTemozolomide: a milestone in neuro-oncology and beyond?Chemosensitized radiosurgery for recurrent brain metastases.Temozolomide added to whole brain radiotherapy in patients with multiple brain metastases of non-small-cell lung cancer: a multicentric Austrian phase II study.The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics.Surgery of recurrent brain metastases: retrospective analysis of 67 patients.Chemotherapy and targeted molecular therapies for brain metastases.Temozolomide for treatment of brain metastases: A review of 21 clinical trials.The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guidelineSystemic treatment of non-small cell lung cancer brain metastasesOptimal management of brain metastases from breast cancer. Issues and considerations.Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC.Brain metastasis: new opportunities to tackle therapeutic resistance.Brain metastases in non-small-cell lung cancer: better outcomes through current therapies and utilization of molecularly targeted approaches.Systemic therapy of brain metastases.Systemic therapies in the treatment of non-small-cell lung cancer brain metastases.[China Experts Consensus on the Diagnosis and Treatment of Brain Metastases of Lung Cancer (2017 version)].Emerging treatment paradigms for brain metastasis in non-small-cell lung cancer: an overview of the current landscape and challenges ahead.Characteristics of patients with brain metastases from lung cancer in a palliative care center.Elemene treatment for NSCLC with multiple CNS metastases: a case report and literature review
P2860
Q24568071-9FE803DE-99B2-4D94-87F4-F375E8EF5F6FQ33372340-46EA333A-C197-4019-BE92-A3B1E7CD5617Q33402904-4BCF531C-6D9F-4CEF-B428-86B30E643B49Q33409478-BA2B7F53-A80E-4526-BAD8-10FE726183B8Q33599167-EA0D6C94-275D-4E70-84F9-435BF432133DQ34891770-B7036A85-CB18-4A3A-85D1-F0F6DBA0C658Q36641504-67599BC0-8289-4A85-BCEF-DD665F187941Q37576025-CA458FB8-CB56-4373-AD61-6801D9757EA3Q37643544-730B0E1B-D7CC-42E4-BD6E-7D469D072AB4Q37727648-F8B38148-DE69-448F-85FD-E3FA0F52F3C2Q38067340-19A16B93-7B86-4926-A99A-9EBCE4CF42A3Q38096437-DC32A0F5-B44F-4348-A0CE-2BE62128937AQ38222247-2F6BF03E-75BD-4D6A-82C3-6AA5C0DBEA93Q38233149-43204B80-662F-43C5-9B5B-C7CFB8F51743Q38285931-832DC10C-64B2-4BF1-A6D3-B1760DE344D8Q38738053-2AACE499-9D01-45E9-9691-69EDAD38FAB3Q40372968-8CF48777-DF2C-484B-99C9-4EAA5D7210E6Q48013012-52A63F4D-E1F0-46C9-AB2A-CC96F53DF800Q48278009-4E262113-616C-4B9C-98C8-88A3B91872A9Q57485207-D26DD447-8124-4095-909D-C9EFB864178E
P2860
Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: phase II study.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Oral temozolomide in heavily p ...... l lung cancer: phase II study.
@en
Oral temozolomide in heavily p ...... l lung cancer: phase II study.
@nl
type
label
Oral temozolomide in heavily p ...... l lung cancer: phase II study.
@en
Oral temozolomide in heavily p ...... l lung cancer: phase II study.
@nl
prefLabel
Oral temozolomide in heavily p ...... l lung cancer: phase II study.
@en
Oral temozolomide in heavily p ...... l lung cancer: phase II study.
@nl
P2093
P1433
P1476
Oral temozolomide in heavily p ...... l lung cancer: phase II study.
@en
P2093
Alessandro Pappalardo
Antonio Russo
Carmelo Giannitto Giorgio
Dario Giuffrida
Giuseppe Failla
Giusy Blanco
Placida Salice
Roberto Bordonaro
P304
P356
10.1016/J.LUNGCAN.2005.05.026
P577
2005-07-20T00:00:00Z